EUVIMED · CrossrefJournal
Cancer Pathogenesis and Therapy
ISSN 2949-7132 · Elsevier BV
Latest articles
From “undruggable” to tractable: Therapeutic advances targeting Kristen rat sarcoma viral homolog glycine to cysteine mutation at codon 12 (KRAS G12C)-mutant cancers and emerging resistance mechanisms
Magnesium isoglycyrrhizinate remodels the inflammatory tumor microenvironment in gastric cancer through inhibition of the phospholipase A2 (PLA2)/nuclear factor κB (NF-κB) signaling axis
Efficacy of homoharringtonine (HHT)-based induction regimen in acute myeloid leukemia (AML) with double-mutated CCAAT/enhancer-binding protein alpha (CEBPA): A prospective multicenter, single-arm phase II trial
CAR-NK cell therapy for hepatocellular carcinoma and other liver diseases: Current evidence and future perspectives
Perspective Mechanisms and Intervention Strategies of T Cell Exhaustion in Chimeric Antigen Receptor T-cell (CAR-T) Therapy
Kirsten rat sarcoma viral oncogene (KRAS) G12D and pan-RAS inhibitors in pancreatic ductal adenocarcinoma: clinical progress and strategies to overcome resistance
Kirsten rat sarcoma viral oncogene (KRAS)-targeted therapy across cancer types: Context, resistance, and future directions
Bridging the Diagnostic Gap in TP53-Mutated Myeloid Neoplasms: From Classification Discrepancies to a Practical cnLOH-Inclusive Diagnostic Framework
DKK1-CKAP4 axis functions as an immunometabolic checkpoint linking tumor-intrinsic signaling with immune suppression
MicroRNA (miRNA) dysregulation in virus-associated cancers: From molecular mechanisms to therapeutic breakthroughs
Mechanistic target of rapamycin complex (mTORC)-glutamine axis in cancer: Mechanistic crosstalk, therapeutic resistance, and clinical opportunities
Safety and efficacy of JWATM204, a novel glypican-3 (GPC3)-targeted chimeric antigen receptor (CAR) T-cell therapy for advanced hepatocellular carcinoma: A phase I dose-escalation study
Rare internal malignancies in xeroderma pigmentosum: A report of two cases from Tunisia and analysis of driver mutations
Longitudinal assessment of biopsy-resection histological discordance in digestive tract epithelial neoplasms and development of a colorectal upgrading prediction model
Cover
Table of Contents
Investigating hypoxia-inducible factor signaling in cancer: Mechanisms, clinical implications, targeted therapeutic strategies, and resistance
Exploring marine-derived compounds as potential anticancer agents: Mechanisms and therapeutic implications
Cover
Table of Contents
Genetically predicted inflammatory mediators link mitochondrial function to breast cancer risk: A Mendelian randomization study
Methionine restriction for cancer therapy: A comprehensive review of mechanisms and clinical applications
Chemoresistance: The hidden barrier in cancer treatment
Cover
Table of Contents
Clotrimazole as a new frontier: Drug repurposing and its efficacy in cancer therapy
Emerging risk factors and the role of gut microbiota in immunomodulation and therapeutic implications in colorectal cancer
Emerging strategies in neoadjuvant therapy for non-small cell lung cancer: Progress and future directions
Inflammatory cytokines and specific factors influencing lung cancer progression
Volatile organic compounds in exhaled breath: Applications in cancer diagnosis and predicting treatment efficacy
EUVIMED